
We help chart the path from clinical to commercial for a new product launch and provide strategies for continued market viability for drugs on the market. Since its inception in 2003, Two Labs has led 280+ new product launches and more than 300+ in-market projects from pre-launch to loss of exclusivity.
Monday, April 27 | 1:00–1:40 PM PST
Moderated by Two Labs Co-Founder Will Pih, the session will explore the evolving cell and gene therapy landscape, covering approval trends, commercialization challenges, and emerging distribution models.

VP, Patient &
Channel Access,
Autolus Therapeutics

VP, Patient & Channel Access, Autolus Therapeutics
Austin Fisher is Vice President, Patient & Channel Access at Autolus Therapeutics, where he supports access and channel strategy for advanced cell and gene therapies. In this position, he and his team focus on aligning patient support, patient journey operations, distribution pathways, and stakeholder engagement to help eligible patients reach treatment efficiently. With deep experience across patient services and channel operations, he is a regular voice in industry forums on commercialization for advanced therapies, speaking on topics such as operations, standardization, innovative purchasing pathways, and navigating complex market environments.

Managing Director
and Consulting Lead,
Riparian

Managing Director
and
Consulting Lead,
Riparian
Jennifer Lospinoso is a seasoned leader with nearly 20 years of experience in government and commercial program operations. Since 2021, she has been a pivotal member of Riparians’ leadership team, where she has significantly contributed to enhancing the company’s reputation as a trusted advisor in the pharmaceutical industry. Her work focuses on developing innovative solutions for pharmaceutical manufacturers involved in government programs and commercial discount strategies.
Before joining Riparian, Jennifer served as a Managing Director at KPMG, where she led projects centered on regulatory compliance, gross-to-net forecasting, and operational excellence. Prior to KPMG, she spent over seven years at Novartis, where she focused on government rebates, contracting, and financial analysis.
Based in Florida, Jennifer is committed to fostering innovation and excellence in her field and continues to drive the development of superior products and results for Riparians’ clients.

SVP, Biopharma
Business Development,
Orsini

SVP, Biopharma
Business Development,
Orsini
Morgan Olson is currently the Senior Vice President of Business Development for Orsini, leading strategic pipeline and business development initiatives for the company’s biopharma segment. Morgan has been with Orsini for three years and previously led commercial operations and marketing.
Prior to Orsini, Morgan held leadership roles in commercial operations at Omada Health. Before that, she spent eight years at McKesson, where led oral oncology product strategy and oncology in-office dispensing pharmacy business within McKesson Specialty Health. She began her career in healthcare research and management, building a strong foundation in clinical and operational strategy.
Morgan earned her MBA and B.S. in Biology from Cornell University. She is passionate about improving patient access to life-changing therapies through innovation, collaboration, and operational excellence.

Head of Distribution
Strategy & Execution,
Bayer Pharmaceuticals US

Head of Distribution
Strategy & Execution,
Bayer Pharmaceuticals US
Stephanie Wirkes is a senior Market Access executive at Bayer Pharmaceuticals US and serves as Head of Distribution Strategy & Execution. She leads Bayer’s Distribution Team, responsible for strategy and account management across trade and specialty distributors, retail and specialty pharmacies, and hospital GPO accounts. Her remit spans multiple therapeutic areas, including women’s health, hemophilia, oncology, and cell and gene therapy, with a focus on ensuring patients can access the right care at the right time and in the right setting, collaborating across functions to deliver seamless launch planning and high-performing distribution models.

Co-Founder,
Two Labs

Co-Founder,
Two Labs


















Envision Pharma Group is a global, technology-enabled solutions partner to the life sciences industry. We unleash the power of combined intelligence— human expertise and technology— to advancing how scientific innovation translates into improved patient outcomes. We unite scientific expertise, strategic insight, and AI-powered technology to help clients create, communicate, and demonstrate value, accelerating access to life-changing treatments.
With more than 20 years of experience and trusted partnerships with 400+ biopharma companies, including all top 20 pharma, we deliver integrated solutions across the product lifecycle, from medical communications to commercialization and compliance, through flexible models that scale to client needs. Together, we combine human insight and technology to drive smarter decisions, measurable impact, and sustainable growth.

110 Riverbend Avenue, Suite 100
Powell, OH 43065
Phone: (614) 389-4004
Fax: (866) 259-4324
Email: info@twolabs.com
© Copyright 2026